Results

Total Results: over 10,000 records

Showing results for "indicated".

  1. preventiveservices.ahrq.gov/sites/default/files/wysiwyg/cpi/about/mission/arra/arracer-slides.pptx
    October 15, 2013 - ) 18% of surveyed consumers reported awareness of CER when prompted with a definition Of those who indicated … ) 21% of surveyed consumers reported awareness of CER when prompted with a definition Of those who indicated … awareness of CER when prompted with its name A larger portion of clinicians indicated awareness of PCOR … vast majority of clinicians (92%) were unaware of the EHC Program Slightly over half of clinicians indicated … awareness of CER when prompted with its name A larger portion of clinicians indicated awareness of PCOR
  2. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2023-hcbs-infographic.pdf
    January 01, 2023 - Disorder Program respondents Highest-Scoring Measure Physical safety 100 percent of respondents indicated … Lowest-Scoring Measure Staff were not available to help with meals 51 percent of respondents indicated
  3. preventiveservices.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2023-hcbs-infographic.pdf
    January 01, 2023 - Disorder Program respondents Highest-Scoring Measure Physical safety 100 percent of respondents indicated … Lowest-Scoring Measure Staff were not available to help with meals 51 percent of respondents indicated
  4. www.qualitymeasures.ahrq.gov/ncepcr/reports/primary-care-research/appendix-a.html
    January 01, 2024 - years old, teen), Young Adult (18–25 years old), Adult (25–65 years old), Elderly (65+ years old), None indicated … : Medicare, Medicaid, Private Insurance, Uninsured, Veterans (VHA), None indicated Race/ethnicity … ethnicity (not-specified): [when race/ethnicity mentioned as a population but is not stratified], None indicated … : Urban/inner city, rural, suburban, None indicated Medical Conditions Studied Chronic Disease ( … Other (multiple): worded as co-occurring multiple chronic disorders but did not specify (MCC) None indicated
  5. ce.effectivehealthcare.ahrq.gov/ncepcr/reports/primary-care-research/appendix-a.html
    January 01, 2024 - years old, teen), Young Adult (18–25 years old), Adult (25–65 years old), Elderly (65+ years old), None indicated … : Medicare, Medicaid, Private Insurance, Uninsured, Veterans (VHA), None indicated Race/ethnicity … ethnicity (not-specified): [when race/ethnicity mentioned as a population but is not stratified], None indicated … : Urban/inner city, rural, suburban, None indicated Medical Conditions Studied Chronic Disease ( … Other (multiple): worded as co-occurring multiple chronic disorders but did not specify (MCC) None indicated
  6. srdr.ahrq.gov/projects/1705/studies/197183
    January 01, 2007 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  7. srdr.ahrq.gov/projects/1705/studies/197192
    January 01, 1998 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  8. srdr.ahrq.gov/projects/1705/studies/197194
    January 01, 2006 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  9. srdr.ahrq.gov/projects/1705/studies/197201
    January 01, 1999 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  10. srdr.ahrq.gov/projects/1705/studies/197206
    infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  11. srdr.ahrq.gov/projects/1705/studies/197182
    January 01, 2005 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  12. srdr.ahrq.gov/projects/1705/studies/197185
    January 01, 2006 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  13. srdr.ahrq.gov/projects/1705/studies/197208
    January 01, 2007 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  14. srdr.ahrq.gov/projects/1705/studies/197195
    January 01, 2002 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  15. srdr.ahrq.gov/projects/1705/studies/197211
    January 01, 1994 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  16. srdr.ahrq.gov/projects/1705/studies/197215
    January 01, 2014 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  17. srdr.ahrq.gov/projects/1705/studies/197217
    January 01, 2004 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  18. srdr.ahrq.gov/projects/1705/studies/197219
    January 01, 2000 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  19. srdr.ahrq.gov/projects/1705/studies/197221
    January 01, 2009 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
  20. srdr.ahrq.gov/projects/1705/studies/197193
    January 01, 1997 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated